AstraZeneca
AZN
AZN
557 hedge funds and large institutions have $19.3B invested in AstraZeneca in 2019 Q1 according to their latest regulatory filings, with 76 funds opening new positions, 141 increasing their positions, 228 reducing their positions, and 69 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
557
Holders Change
+1
Holders Change %
+0.18%
% of All Funds
12.07%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.13%
New
76
Increased
141
Reduced
228
Closed
69
Calls
$91.5M
Puts
$101M
Net Calls
-$9.65M
Net Calls Change
-$73.1M
Top Buyers
| 1 |
Winslow Capital Management
Minneapolis,
Minnesota
|
+$253M |
| 2 |
Morgan Stanley
New York
|
+$210M |
| 3 |
Capital World Investors
Los Angeles,
California
|
+$100M |
| 4 |
O
OppenheimerFunds
New York
|
+$97.2M |
| 5 |
GQG Partners
Ft. Lauderdale,
Florida
|
+$87M |
Top Sellers
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$249M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$108M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$102M |
| 4 |
Jennison Associates
New York
|
-$94.4M |
| 5 |
EIP
Epoch Investment Partners
New York
|
-$48M |
